Athens, May 19, 2017. BIONIME has sponsored a Clinical Study at the First Department of Propaedeutic and Internal Medicine, Laiko General Hospital of Athens, entitled: Evaluation of the accuracy according to the ISO 15197:2013 requirements and usability of 6 different commercially available self-monitoring blood glucose monitoring systems (SMBG).

The Clinical Study was conducted in August 2016 and Dr.Nikolaos Tentolouris, Deputy Professor of the Medical School of the University of Athens in the First Pediatric Clinic with a subject “Pathology Diabetes Mellitus”, was the primary investigator.

Also, the clinical study was presented with a poster at the 10th International Conference ATTD (ADVANCED TECHNOLOGIES & TREATMENTS FOR DIABETES), 15-18 February, 2017, in Paris.

The aim of the Clinical Study was to evaluate the accuracy according to the ISO 15197:2013 Requirements as well as the usability of 6 different commercially available self-monitoring blood glucose monitoring systems (SMBG).

Knowing how important and necessary is self-monitoring of blood glucose to achieve glycemic control in people with diabetes, BIONIME has conducted the clinical study and today presents the results in the following Table.

 

Find here the Clinical Study

Find here the Poster of Clinical Study